Digest Network Come funziona
Network
/
Società
De
Non verificato

Definium Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

45 comunicati stampa

Guarda tutti i comunicati
14/09/2026
Scienza
Psichiatria
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Web e Social Network
Industria
Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/09/2026
Mercato del lavoro
Finanza
Mercato azionario
Medicina alternativa
Psichiatria
Salute
Farmaceutica
Biotecnologia
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
13/09/2026
Web e Social Network
Industria
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Medicina alternativa
Salute
Farmaceutica
Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
10/09/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/09/2026
Industria
Psichiatria
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
31/08/2026
Mercato azionario
Psichiatria
Scienza
Biotecnologia
Sanità
Salute
Farmaceutica
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
26/08/2026
Web e Social Network
Eventi
Industria
Scienza
Sanità
Farmaceutica
Oncologia
Psichiatria
Medicina - Varie
Biotecnologia
Medicina alternativa
Salute
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
17/08/2026
Mercato azionario
Finanza
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/08/2026
Web e Social Network
Industria
Psichiatria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0